Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.57
MJN's Cash to Debt is ranked higher than
53% of the 1509 Companies
in the Global Packaged Foods industry.

( Industry Median: 0.50 vs. MJN: 0.57 )
Ranked among companies with meaningful Cash to Debt only.
MJN' s Cash to Debt Range Over the Past 10 Years
Min: 0.2  Med: 0.67 Max: N/A
Current: 0.57
Equity to Asset -0.16
MJN's Equity to Asset is ranked lower than
97% of the 1474 Companies
in the Global Packaged Foods industry.

( Industry Median: 0.52 vs. MJN: -0.16 )
Ranked among companies with meaningful Equity to Asset only.
MJN' s Equity to Asset Range Over the Past 10 Years
Min: -1.03  Med: -0.01 Max: 0.49
Current: -0.16
-1.03
0.49
Interest Coverage 12.97
MJN's Interest Coverage is ranked lower than
55% of the 1019 Companies
in the Global Packaged Foods industry.

( Industry Median: 16.98 vs. MJN: 12.97 )
Ranked among companies with meaningful Interest Coverage only.
MJN' s Interest Coverage Range Over the Past 10 Years
Min: 11.78  Med: 16.07 Max: 9999.99
Current: 12.97
11.78
9999.99
F-Score: 6
Z-Score: 5.54
M-Score: -2.82
WACC vs ROIC
10.99%
92.69%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 23.00
MJN's Operating margin (%) is ranked higher than
92% of the 1502 Companies
in the Global Packaged Foods industry.

( Industry Median: 4.84 vs. MJN: 23.00 )
Ranked among companies with meaningful Operating margin (%) only.
MJN' s Operating margin (%) Range Over the Past 10 Years
Min: 21.41  Med: 23.68 Max: 28.09
Current: 23
21.41
28.09
Net-margin (%) 16.05
MJN's Net-margin (%) is ranked higher than
91% of the 1506 Companies
in the Global Packaged Foods industry.

( Industry Median: 3.07 vs. MJN: 16.05 )
Ranked among companies with meaningful Net-margin (%) only.
MJN' s Net-margin (%) Range Over the Past 10 Years
Min: 13.67  Med: 15.58 Max: 17.7
Current: 16.05
13.67
17.7
ROE (%) 189.98
MJN's ROE (%) is ranked higher than
100% of the 1479 Companies
in the Global Packaged Foods industry.

( Industry Median: 6.35 vs. MJN: 189.98 )
Ranked among companies with meaningful ROE (%) only.
MJN' s ROE (%) Range Over the Past 10 Years
Min: 69.46  Med: 86.31 Max: 440.45
Current: 189.98
69.46
440.45
ROA (%) 16.85
MJN's ROA (%) is ranked higher than
93% of the 1536 Companies
in the Global Packaged Foods industry.

( Industry Median: 3.16 vs. MJN: 16.85 )
Ranked among companies with meaningful ROA (%) only.
MJN' s ROA (%) Range Over the Past 10 Years
Min: 19.27  Med: 22.02 Max: 35.01
Current: 16.85
19.27
35.01
ROC (Joel Greenblatt) (%) 102.16
MJN's ROC (Joel Greenblatt) (%) is ranked higher than
95% of the 1524 Companies
in the Global Packaged Foods industry.

( Industry Median: 11.46 vs. MJN: 102.16 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
MJN' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 112.11  Med: 129.84 Max: 252.05
Current: 102.16
112.11
252.05
Revenue Growth (3Y)(%) 6.60
MJN's Revenue Growth (3Y)(%) is ranked higher than
64% of the 1296 Companies
in the Global Packaged Foods industry.

( Industry Median: 3.20 vs. MJN: 6.60 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
MJN' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 0.40 Max: 10.7
Current: 6.6
0
10.7
EBITDA Growth (3Y)(%) 8.70
MJN's EBITDA Growth (3Y)(%) is ranked higher than
62% of the 1100 Companies
in the Global Packaged Foods industry.

( Industry Median: 3.00 vs. MJN: 8.70 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
MJN' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: -4.60 Max: 12.9
Current: 8.7
0
12.9
EPS Growth (3Y)(%) 12.70
MJN's EPS Growth (3Y)(%) is ranked higher than
66% of the 999 Companies
in the Global Packaged Foods industry.

( Industry Median: 3.20 vs. MJN: 12.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
MJN' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: -3.80 Max: 15
Current: 12.7
0
15
» MJN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

MJN Guru Trades in Q1 2015

Joel Greenblatt 8,665 sh (New)
Lee Ainslie 2,480 sh (New)
Steven Cohen 823,400 sh (+119.69%)
Jim Simons 985,000 sh (+78.38%)
John Hussman 175,000 sh (+75.00%)
George Soros 70,000 sh (+40.00%)
Louis Moore Bacon 20,000 sh (+33.33%)
Robert Karr 452,500 sh (+2.86%)
Pioneer Investments 719,818 sh (+0.27%)
RS Investment Management Sold Out
Ray Dalio Sold Out
Manning & Napier Advisors, Inc Sold Out
David Rolfe 2,594,166 sh (-0.83%)
MS Global Franchise Fund 31,751 sh (-3.59%)
Mario Gabelli 132,841 sh (-4.50%)
» More
Q2 2015

MJN Guru Trades in Q2 2015

Paul Tudor Jones 24,403 sh (New)
John Burbank 2,224 sh (New)
Joel Greenblatt 198,929 sh (+2195.78%)
Jim Simons 2,108,000 sh (+114.01%)
Robert Karr 772,300 sh (+70.67%)
Pioneer Investments 793,095 sh (+10.18%)
Lee Ainslie 2,700 sh (+8.87%)
David Rolfe 2,730,152 sh (+5.24%)
George Soros 70,000 sh (unchged)
Louis Moore Bacon 30,000 sh (unchged)
Louis Moore Bacon Sold Out
MS Global Franchise Fund 29,817 sh (-6.09%)
Mario Gabelli 108,511 sh (-18.32%)
John Hussman 50,000 sh (-71.43%)
Steven Cohen 41,800 sh (-94.92%)
» More
Q3 2015

MJN Guru Trades in Q3 2015

Ray Dalio 118,768 sh (New)
Manning & Napier Advisors, Inc 87,530 sh (New)
Louis Moore Bacon 10,000 sh (New)
Joel Greenblatt 687,078 sh (+245.39%)
George Soros 130,000 sh (+85.71%)
Paul Tudor Jones 44,145 sh (+80.90%)
Jim Simons 2,963,300 sh (+40.57%)
David Rolfe 3,497,161 sh (+28.09%)
Pioneer Investments 940,701 sh (+18.61%)
Lee Ainslie 3,150 sh (+16.67%)
John Hussman 50,000 sh (unchged)
Louis Moore Bacon 30,000 sh (unchged)
John Burbank Sold Out
Steven Cohen Sold Out
MS Global Franchise Fund 28,767 sh (-3.52%)
Mario Gabelli 96,231 sh (-11.32%)
Robert Karr 647,300 sh (-16.19%)
» More
Q4 2015

MJN Guru Trades in Q4 2015

Pioneer Investments 1,088,094 sh (+15.67%)
John Hussman Sold Out
Robert Karr Sold Out
Mario Gabelli 93,730 sh (-2.60%)
Ray Dalio 23,153 sh (-80.51%)
Jim Simons 39,200 sh (-98.68%)
» More
» Details

Insider Trades

Latest Guru Trades with MJN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Guru Investment Theses on Mead Johnson Nutrition Co

David Rolfe Comments on Mead Johnson - Oct 15, 2015

Mead Johnson (NYSE:MJN) was another stock we incrementally added to during the quarter. We think news of increased price competition in the Chinese infant formula market is related to short-term distribution channel shifts, while the market perceives it as a threat to MJN's long-term earnings power. Importantly, we think very little of Mead Johnson's long-term value-added stems from manipulating channel economics. Instead, we think MJN's roughly, century-old track record of producing safe and scientifically differentiated infant formula continues to offer exceptional value relative to unproven, albeit cheaper, competing products - particularly in markets with less developed food supplies.

We estimate that up to about a third of Mead Johnson's revenues are derived from Chinese mainland demand, with the Company supplying this market through four distribution channels. While that strikes us as being a particularly inefficient way to serve a market, we have thus far concluded it to be a necessary evil, more reflective of consumer culture and preference, and less indicative of any sort of supply-driven logic. Regardless, Mead Johnson continues to invest in its Chinese distribution efforts, especially given recent changes related to the easing of China's notorious family planning (e.g. "one child") policies, which could well likely open the door to an expanding addressable market. With shares trading near historically attractive levels relative to MJN's earnings prospects, we added to positions.

From David Rolfe (Trades, Portfolio)'s Wedgewood Partners third quarter 2015 letter.

Check out David Rolfe latest stock trades

David Rolfe Comments on Mead Johnson Nutrition - Apr 18, 2014

Mead Johnson Nutrition (MJN)

Edward Mead Johnson: founder of not one, but two great companies in his lifetime. Now, how many of us can say that?! In 1885, after graduating from the University of Michigan with a degree in law, he and his two brothers, Robert Wood Johnson I and James Wood Johnson, would found Johnson & Johnson, the consumer healthcare products company in Brunswick, New Jersey. With no lack of success, Edward soon 15 decided he wanted to do more. Ten short years later, he broke off from Johnson & Johnson and founded American Ferment Company in Jersey City, N.J., making nutritional products. Fast forward another ten years, in 1905 American Ferment re-­‐ established itself as Mead Johnson and Company and the +100 year history of the Mead Johnson Nutrition Company begins. While Mead Johnson's name has remained intact throughout its history, the company – with sales then of $131 million – was acquired in 1967 by Bristol-­‐Myers for $240 million. Bristol-­‐Myers Squibb owned Mead Johnson as a wholly owned subsidiary for the next four decades until they announced in April 2008 plans to sell 10-­‐20% of Mead Johnson to the public through an IPO in order to better focus on its burgeoning biopharmaceutical business. Bristol-­‐Myers Squibb would proceed to split off Mead Johnson and by February 2009 the IPO was complete. Shortly thereafter, in November of 2009, Bristol-­‐Myers would spin out the rest of their ownership of Mead Johnson in a stock swap, valued at $7.7 billion. Mead Johnson Nutrition would operate as a fully independent public company going forward.

Edward Mead Johnson's decision to break away from Johnson and Johnson stemmed from a personal experience that also drove a strong desire to work on nutritionals, primarily in digestive aids. In 1888, Johnson's first child was born, sadly enough, with a feeding disorder and congenital heart defect that required Johnson to prepare a physician-­‐directed product to feed the child. This was a time in history where, in some U.S. cities, up to 30% of infants died before reaching their first birthday (cdc.gov) with leading causes attributed to gastrointestinal disorders and infant digestive problems. Needless to say, Johnson had much motivation. In 1911, the company launched its first infant feeding nutritional product, Dextri Maltose, a carbohydrate powder mixed with milk. It went on to be the first clinically supported, physician-­‐recommended (not to mention the company's best-­‐selling) infant feeding product in the U.S. This product laid the foundation for Mead Johnson's later flagship infant nutritional product, Enfamil.

During World War I, the company could no longer import potato starch (Dextri Maltose's source of carbohydrate) from Germany and was forced to relocate to America's breadbasket where they could have access to an alternate supply of carbohydrates. The company settled in Evansville, Indiana where they found ample supplies of corn, their new source of carbohydrates. Today, the company maintains its Global Operations Center in Evansville. (As an aside, a friend of the firm has its own ties to Mead Johnson via Dextri Maltose and their move to Evansville. After relocating to Evansville, Mead Johnson had difficulty with the production of their best-­‐selling product. Mead Johnson teamed up with George Koch Sons, Inc. who provided packaging containers for Dextri Maltose. Mead Johnson would go on to use Koch packaging exclusively for nearly two decades.)

Over the coming decades, Mead Johnson produced numerous nutritional science breakthroughs. Casec, its first milk-­‐derived product, was introduced in the 1920's to assist gastrointestinal disorders and infant digestive problems – two of the leading causes of death in infants in the United States at the time. According to the 16 National Institute of Health, two-­‐thirds of American children in the early 1900's suffered from rickets – a disorder caused by a lack of vitamin D, calcium, and phosphate, and leads to softening and weakening of bones. Mead Johnson found that cod liver oil provided a source of vitamin D and the company introduced a product that allowed doctors to administer a standardized dose of the supplement. In 1931, the Company introduced the processed (dry and precooked) infant cereal Pablum. The considerable success of Pablum was due to its ease of preparation. Pablum was easily tolerable for infants, and it contained considerable amount of vitamins and minerals. Pablum was sold to H. J. Heinz in 2005.

Mead Johnson introduced its reconstructed milk, Recolac and Powdered Lactid Acid Half Skim Milk in the mid-­‐1920's. Reconstructed milk breaks cow's milk into its major nutritional components and reassembles them, along with other ingredients, into combinations thought to be more appropriate for infant feeding. Olac was later introduced which used vegetable oils rather than animal fats as a fat component.

Sobee Powder was one of the company's initial products, developed shortly after Recolac. This was the first powder produced by Mead Johnson that offered soybean flour as a source of protein for children allergic to the protein in cow's milk. Nearly two decades later, the company developed Mutramigen, the first protein hydrolysate formula in the U.S. for infants with cow's milk protein allergies. This product was a breakthrough in nutrition and remains today one of Mead Johnson's most important products. ProSobee, introduced in the 1960's, was the first infant formula in the U.S. with soy protein isolated from whole soy flour.

Mead Johnson introduced its first baby formula in 1911 and over the century expanded into vitamins, pharmaceutical products, and prenatal nutrition. Enfamil, undoubtedly the brand most recognized today in the United States, was first introduced in the 1950's in both powder form and concentrated liquid. Enfamil was the first routine infant formula patterned after the nutritional composition of human milk. Throughout the years, Enfamil underwent several modifications to improve the formulation in order to keep up with the advancement of science and pediatric nutrition.

Today, the Company's Enfamil brand is recognized worldwide for its leadership in pediatric nutrition. In 1978, a major manufacturer of infant formula (and competitor of Mead Johnson) reformulated two of its soy products, resulting in infant formula products that contained inadequate amount of chloride, an essential nutrient for growth and development in infants. By mid-­‐1979, a substantial number of infants were diagnosed with a syndrome associated with chloride deficiency. What soon followed was a criminal investigation by the U.S. Department of Justice, but more importantly, the passage of the Infant Formula Act of 1980 and its subsequent amendments in 1986. The Act established provisions for current good manufacturing practices (CGMP), quality control, nutrient requirements, and quality factors indicating that infant formulas marketed in the United States should be safe and contain all of the nutrients required to support infant growth and health.

During the legislative history of the Act, one Senator stated why infant formula needs more regulation than other foods: "…there is simply no margin for error in the production of baby formula. An infant relies on the formula to sustain life and provide the proper nourishment at a time of rapid physical and mental development" (fda.gov). The regulations have directly resulted in decreased competition in the industry.

The Company has developed numerous other infant and children's nutritional formulas and supplements. Also found on their list of achievements, Mead Johnson developed products that aid in the treatment for respiratory problems as well as the first weight loss product. For those readers who are over the age of, say 60, may remember the unintended pop culture phenomenon of the Company's weight-­‐loss product Metrecal. Metrecal was essentially this country's first diet protein shake that actually worked. Launched in late 1959, Metrecal was first a powder made up of corn oil, soybean flour and powdered skim milk, plus the powder was loaded with vitamins, minerals and protein. Mixed with water, Metrecal was a 900 calorie-­‐per-­‐day daily diet plan that literally worked wonders. (How could it not when consuming just 900 calories per day?!) A year later the Company introduced Metrecal in a pre-­‐mixed liquid can. As Metrecal moved from the pharmacy, to the kitchen, then on to the nation's patios in the early 1960's, the country's diet craze was in full swing – even Bergdorf Goodman made a high society purse flask that "could be the solution for every secret Metrecal drinker."

So successful was Metrecal that the Company formed an exclusive division (the Edward Dalton Company) for its production and marketing. The Company would proceed to rollout Metrecal milkshakes, Metrecal clam chowder, Metrecal cookies and Metrecal noodles and tuna. By 1965, the Metrecal franchise peaked and would lose its dominance in the 1970's to other crash-­‐diet products – particularly Slim-­‐Fast. By the late 1970's, due to a rash of deaths, the FDA pulled Metrecal and many similar products off the market.

Today, the company's worldwide recognition equates to over 70 products in more than 50 markets leading to a global share of 14% in the infant formula market – a #2 ranking. Mead Johnson International was formed in the mid-­‐1950's to provide a framework for conducting business overseas. Its first Mexican manufacturing facility was built in Mexico City, which today is the site of the company's Latin American regional headquarters. In the 1960's Mead Johnson constructed manufacturing facilities in the Philippines to support their growing presence in Asia. In the 1980's the company expanded into Western Europe, initially offering nutrition products for infants and older babies. Expansion into Central and Eastern Europe soon followed. Over the years, Mead Johnson would continue to develop and introduce formulas in different markets internationally.

Mead Johnson Nutrition Company has three reportable segments – Asia, Latin America, and North America/Europe – which comprised 52%, 20%, and 28% respectively of net sales for the calendar year. In total, 77% of the company's net 18 sales were generated in countries outside the United States. The Asia-­‐Pacific region, alone will likely account for 50% of future global growth. We have identified several drivers of the growth in these regions. In late 2013, China announced it would loosen its one-­‐child policy, allowing couples to have two children so long as one of the parents is an only child. By our estimates, this could expand the total addressable market for pediatric nutrition by a few billion dollars per annum. In addition, the 2008 milk and infant formula scandal has had a long-­‐lasting and material impact on the Chinese infant formula market. Melamine, a toxic chemical used in milk products to artificially boost protein, sickened an estimated 300,000 children. More than 50,000 children were hospitalized and six died from kidney damage. As a result of this scandal, Western brands garnered preferred trust and premium pricing as China, plus other regions, continue to lack the availability of high quality children's nutrition and a mature food supply. We are also seeing a demographic shift of more women in the work force, which will likely increase the use of infant formula and children's nutrition.

Mead Johnson Nutrition has more than a century of research and development, resulting in superior quality, consumer loyalty and leading profitability. As the strict regulations outlined above detail, the FDA scrutinizes the quality of infant formula, creating significant barriers to entry, particularly in the United States. As such, there are three brand-­‐name infant formula manufacturers that control over 80% market share in the U.S., Mead Johnson included. Further, the Company's R&D efforts have led to products with tangible, scientifically proven benefits to newborns, which is a proven differentiator relative to competing products and substitutes (e.g. breast feeding). For instance, outside of the U.S., Mead Johnson boasts the first formula, EFSA-­‐approved (i.e. Europe's FDA) Nutramigen LIPIL, which has proven benefits for visual development superior to those offered by breast milk.

While Mead Johnson has exceptional fundamental characteristics, our process dictates that the stock exhibit a valuation that is just as compelling. We have been following the Company since 2010, and have waited patiently for the stock to trade at the lower end of its valuation range, relative to other investment opportunities. During the quarter, sensible valuation levels came to pass, mostly due to a pullback in shares on near-­‐term concerns about earnings growth, as well as a paucity of cheap investment alternatives. However, we continue to believe that Mead Johnson has an exceptional value proposition that is capable of generating double digit EPS growth through a combination of price increases, share gains and cost containment. As a result of this attractive relative valuation and fundamental outlook, we initiated a new position in Mead Johnson.



From David Rolfe (Trades, Portfolio)'s Wedgewood Partners first quarter 2014 commentary.

Check out David Rolfe latest stock trades

Top Ranked Articles about Mead Johnson Nutrition Co

David Rolfe Comments on Mead Johnson Guru stock highlight
Mead Johnson (NYSE:MJN) was another stock we incrementally added to during the quarter. We think news of increased price competition in the Chinese infant formula market is related to short-term distribution channel shifts, while the market perceives it as a threat to MJN's long-term earnings power. Importantly, we think very little of Mead Johnson's long-term value-added stems from manipulating channel economics. Instead, we think MJN's roughly, century-old track record of producing safe and scientifically differentiated infant formula continues to offer exceptional value relative to unproven, albeit cheaper, competing products - particularly in markets with less developed food supplies. Read more...
The State of the Market - Oct. 10 Insider trading says things may slow down. Here are three names that should do well regardless
The State of the Markets - Oct. 10, 2015 Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 20.96
MJN's P/E(ttm) is ranked higher than
50% of the 1696 Companies
in the Global Packaged Foods industry.

( Industry Median: 20.60 vs. MJN: 20.96 )
Ranked among companies with meaningful P/E(ttm) only.
MJN' s P/E(ttm) Range Over the Past 10 Years
Min: 12.51  Med: 26.19 Max: 33.71
Current: 20.96
12.51
33.71
Forward P/E 17.95
MJN's Forward P/E is ranked lower than
60% of the 765 Companies
in the Global Packaged Foods industry.

( Industry Median: 16.23 vs. MJN: 17.95 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 20.96
MJN's PE(NRI) is ranked higher than
51% of the 1277 Companies
in the Global Packaged Foods industry.

( Industry Median: 20.90 vs. MJN: 20.96 )
Ranked among companies with meaningful PE(NRI) only.
MJN' s PE(NRI) Range Over the Past 10 Years
Min: 12.57  Med: 26.19 Max: 33.58
Current: 20.96
12.57
33.58
P/S 3.39
MJN's P/S is ranked lower than
94% of the 1977 Companies
in the Global Packaged Foods industry.

( Industry Median: 0.83 vs. MJN: 3.39 )
Ranked among companies with meaningful P/S only.
MJN' s P/S Range Over the Past 10 Years
Min: 1.59  Med: 3.94 Max: 4.83
Current: 3.39
1.59
4.83
PFCF 21.36
MJN's PFCF is ranked higher than
54% of the 1086 Companies
in the Global Packaged Foods industry.

( Industry Median: 23.22 vs. MJN: 21.36 )
Ranked among companies with meaningful PFCF only.
MJN' s PFCF Range Over the Past 10 Years
Min: 12.28  Med: 28.28 Max: 50.57
Current: 21.36
12.28
50.57
POCF 17.03
MJN's POCF is ranked lower than
61% of the 1493 Companies
in the Global Packaged Foods industry.

( Industry Median: 13.44 vs. MJN: 17.03 )
Ranked among companies with meaningful POCF only.
MJN' s POCF Range Over the Past 10 Years
Min: 10.11  Med: 21.91 Max: 39.08
Current: 17.03
10.11
39.08
EV-to-EBIT 15.15
MJN's EV-to-EBIT is ranked higher than
55% of the 1806 Companies
in the Global Packaged Foods industry.

( Industry Median: 16.19 vs. MJN: 15.15 )
Ranked among companies with meaningful EV-to-EBIT only.
MJN' s EV-to-EBIT Range Over the Past 10 Years
Min: 9.5  Med: 18.50 Max: 23
Current: 15.15
9.5
23
EV-to-EBITDA 13.75
MJN's EV-to-EBITDA is ranked lower than
54% of the 1886 Companies
in the Global Packaged Foods industry.

( Industry Median: 12.51 vs. MJN: 13.75 )
Ranked among companies with meaningful EV-to-EBITDA only.
MJN' s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.8  Med: 16.90 Max: 21
Current: 13.75
8.8
21
PEG 2.50
MJN's PEG is ranked lower than
53% of the 511 Companies
in the Global Packaged Foods industry.

( Industry Median: 2.29 vs. MJN: 2.50 )
Ranked among companies with meaningful PEG only.
MJN' s PEG Range Over the Past 10 Years
Min: 1.94  Med: 3.01 Max: 5.46
Current: 2.5
1.94
5.46
Current Ratio 2.04
MJN's Current Ratio is ranked higher than
65% of the 1474 Companies
in the Global Packaged Foods industry.

( Industry Median: 1.58 vs. MJN: 2.04 )
Ranked among companies with meaningful Current Ratio only.
MJN' s Current Ratio Range Over the Past 10 Years
Min: 0.29  Med: 1.56 Max: 2.13
Current: 2.04
0.29
2.13
Quick Ratio 1.61
MJN's Quick Ratio is ranked higher than
71% of the 1473 Companies
in the Global Packaged Foods industry.

( Industry Median: 1.05 vs. MJN: 1.61 )
Ranked among companies with meaningful Quick Ratio only.
MJN' s Quick Ratio Range Over the Past 10 Years
Min: 0.15  Med: 1.17 Max: 1.66
Current: 1.61
0.15
1.66
Days Inventory 134.54
MJN's Days Inventory is ranked lower than
81% of the 1426 Companies
in the Global Packaged Foods industry.

( Industry Median: 66.21 vs. MJN: 134.54 )
Ranked among companies with meaningful Days Inventory only.
MJN' s Days Inventory Range Over the Past 10 Years
Min: 54.62  Med: 115.90 Max: 124.36
Current: 134.54
54.62
124.36
Days Sales Outstanding 31.19
MJN's Days Sales Outstanding is ranked higher than
61% of the 1086 Companies
in the Global Packaged Foods industry.

( Industry Median: 39.52 vs. MJN: 31.19 )
Ranked among companies with meaningful Days Sales Outstanding only.
MJN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 27.38  Med: 33.84 Max: 45.61
Current: 31.19
27.38
45.61
Days Payable 120.76
MJN's Days Payable is ranked higher than
87% of the 1062 Companies
in the Global Packaged Foods industry.

( Industry Median: 43.24 vs. MJN: 120.76 )
Ranked among companies with meaningful Days Payable only.
MJN' s Days Payable Range Over the Past 10 Years
Min: 51.93  Med: 116.14 Max: 135.35
Current: 120.76
51.93
135.35

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 2.35
MJN's Dividend Yield is ranked higher than
57% of the 1773 Companies
in the Global Packaged Foods industry.

( Industry Median: 2.05 vs. MJN: 2.35 )
Ranked among companies with meaningful Dividend Yield only.
MJN' s Dividend Yield Range Over the Past 10 Years
Min: 0.5  Med: 1.54 Max: 2.38
Current: 2.35
0.5
2.38
Dividend Payout 0.48
MJN's Dividend Payout is ranked lower than
59% of the 1019 Companies
in the Global Packaged Foods industry.

( Industry Median: 0.40 vs. MJN: 0.48 )
Ranked among companies with meaningful Dividend Payout only.
MJN' s Dividend Payout Range Over the Past 10 Years
Min: 0.3  Med: 0.41 Max: 0.65
Current: 0.48
0.3
0.65
Dividend Growth (3y) 13.00
MJN's Dividend Growth (3y) is ranked higher than
76% of the 646 Companies
in the Global Packaged Foods industry.

( Industry Median: 2.50 vs. MJN: 13.00 )
Ranked among companies with meaningful Dividend Growth (3y) only.
MJN' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 26
Current: 13
0
26
Forward Dividend Yield 2.38
MJN's Forward Dividend Yield is ranked higher than
55% of the 1541 Companies
in the Global Packaged Foods industry.

( Industry Median: 2.12 vs. MJN: 2.38 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 5.51
MJN's Yield on cost (5-Year) is ranked higher than
82% of the 1780 Companies
in the Global Packaged Foods industry.

( Industry Median: 2.02 vs. MJN: 5.51 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
MJN' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 1.17  Med: 3.61 Max: 5.58
Current: 5.51
1.17
5.58
3-Year Average Share Buyback Ratio 0.40
MJN's 3-Year Average Share Buyback Ratio is ranked higher than
82% of the 763 Companies
in the Global Packaged Foods industry.

( Industry Median: -1.20 vs. MJN: 0.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
MJN' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -6.4  Med: 0.40 Max: 0
Current: 0.4
-6.4
0

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 2.17
MJN's Price/Projected FCF is ranked lower than
66% of the 1085 Companies
in the Global Packaged Foods industry.

( Industry Median: 1.40 vs. MJN: 2.17 )
Ranked among companies with meaningful Price/Projected FCF only.
MJN' s Price/Projected FCF Range Over the Past 10 Years
Min: 2.16  Med: 3.24 Max: 6.32
Current: 2.17
2.16
6.32
Price/Median PS Value 0.86
MJN's Price/Median PS Value is ranked higher than
71% of the 1916 Companies
in the Global Packaged Foods industry.

( Industry Median: 1.32 vs. MJN: 0.86 )
Ranked among companies with meaningful Price/Median PS Value only.
MJN' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.44  Med: 1.00 Max: 1.18
Current: 0.86
0.44
1.18
Price/Peter Lynch Fair Value 2.39
MJN's Price/Peter Lynch Fair Value is ranked lower than
56% of the 394 Companies
in the Global Packaged Foods industry.

( Industry Median: 1.58 vs. MJN: 2.39 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
MJN' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 1.89  Med: 3.04 Max: 4.74
Current: 2.39
1.89
4.74
Price/Graham Number 9.76
MJN's Price/Graham Number is ranked lower than
91% of the 1533 Companies
in the Global Packaged Foods industry.

( Industry Median: 1.34 vs. MJN: 9.76 )
Ranked among companies with meaningful Price/Graham Number only.
MJN' s Price/Graham Number Range Over the Past 10 Years
Min: 6.24  Med: 9.52 Max: 14.59
Current: 9.76
6.24
14.59
Earnings Yield (Greenblatt) (%) 6.62
MJN's Earnings Yield (Greenblatt) (%) is ranked higher than
62% of the 1482 Companies
in the Global Packaged Foods industry.

( Industry Median: 4.90 vs. MJN: 6.62 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
MJN' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 4.4  Med: 5.40 Max: 10.5
Current: 6.62
4.4
10.5
Forward Rate of Return (Yacktman) (%) 12.71
MJN's Forward Rate of Return (Yacktman) (%) is ranked higher than
74% of the 698 Companies
in the Global Packaged Foods industry.

( Industry Median: 3.69 vs. MJN: 12.71 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
MJN' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 1.9  Med: 11.35 Max: 15.4
Current: 12.71
1.9
15.4

More Statistics

Revenue(Mil) $4071
EPS $ 3.26
Beta1.34
Short Percentage of Float5.53%
52-Week Range $65.53 - 105.45
Shares Outstanding(Mil)197.13

Analyst Estimate

Dec16 Dec17 Dec18
Revenue(Mil) 3,965 4,159 4,326
EPS($) 3.25 3.86 4.28
EPS without NRI($) 3.25 3.86 4.28

Latest Earnings Webcast

» More Conference Calls

Business Description

Industry: Consumer Packaged Goods » Packaged Foods
Compare: » details
Traded in other countries:0MJA.Germany,
Mead Johnson Nutrition Co is a Delaware corporation founded in 1905. The Company manufactures, distributes and sells infant formulas, children's nutrition and other nutritional products. Its comprehensive product portfolio addresses a broad range of nutritional needs for infants, children and expectant and nursing mothers. It markets its portfolio of more than 70 products to mothers, health care professionals and retailers in more than 50 countries in North America, Europe, Asia and Latin America. Its three reportable segments are Asia, Latin America and North America/Europe, which comprised 52%, 20% and 28%, respectively. Its pediatric nutrition products are grouped by category of feeding: infant formula products, children's nutrition products and other products. The Enfa family of brands includes several infant formula and children's nutrition brands. In addition to the Enfa family of brands, it markets several other powerful brands on a local, and regional basis. The Company competes in two primary categories, infant formula and children's nutrition. The Company is subject to numerous governmental regulations, and it can be costly to comply with these regulations. Its products are sold principally to wholesale and retail customers, both nationally and internationally. Its main competitors for sales of infant formula and children's nutrition products are Abbott Laboratories, Danone and Nestlé S.A. The Company maintains more than 6,100 trademark registrations and applications in more than 100 countries. The Company is subject to the laws and regulations in each country in which it markets its products.
» More Articles for MJN

Headlines

Articles On GuruFocus.com
eBay, Visa Among Companies With High Greenblatt ROC Jan 07 2016 
'Tiger Cub' Robert Karr Sells Cisco, Trims Amazon Holding Dec 03 2015 
David Rolfe Comments on Mead Johnson Oct 15 2015 
The State of the Market - Oct. 10 Oct 10 2015 
Tyson Foods Is a Stable Company Among its Peers Aug 31 2015 
Officers and Directors Say "It's Time to Buy" Aug 30 2015 
John Hussman Shakes Up Portfolio in Second Quarter Aug 01 2015 
Despite Industry's Risk, I would bet on Tyson Foods Jun 22 2015 
Robert Karr Raises Stake in Yelp, Reduces Google in First Quarter Jun 05 2015 
Robert Karr's Top Growth Stocks May 08 2015 

More From Other Websites
Tracking Volatility in Prices -- Research on Twenty-First Century Fox, General Mills, Mead Johnson... Feb 10 2016
Mead Johnson’s Gross Margin Benefited from Lower Dairy Prices Feb 02 2016
Morning Analysis on Processed & Packaged Goods Equities -- Mead Johnson Nutrition, Kellogg,... Feb 02 2016
Mead Johnson: China Formula For 24% Upside? Feb 01 2016
Mead Johnson Nutrition Co. Earnings Analysis: Q4, 2015 By the Numbers Feb 01 2016
How Ackman Is Playing It All Wrong Jan 30 2016
How Did Mead Johnson’s Stock React to the Fiscal 4Q15 Results? Jan 29 2016
Mead Johnson Is Trading below Key Moving Averages Jan 29 2016
Mead Johnson Q4 Earnings, Sales Top Estimates: Fall Y/Y Jan 28 2016
Edited Transcript of MJN earnings conference call or presentation 28-Jan-16 2:30pm GMT Jan 28 2016
Mead Johnson Nutrition (MJN) Stock Climbs on Earnings Beat Jan 28 2016
Mead Johnson Nutrition Delivers Earnings Per Share Above Guidance for Fourth Quarter and Full Year... Jan 28 2016
Mead Johnson Nutrition Co Earnings Call scheduled for 9:30 am ET today Jan 28 2016
Mead Johnson (MJN) Beats Q4 Earnings, Revenues; Shares Rise Jan 28 2016
Mead Johnson tops Street 4Q forecasts Jan 28 2016
Mead Johnson tops Street 4Q forecasts Jan 28 2016
MEAD JOHNSON NUTRITION CO Files SEC form 8-K, Results of Operations and Financial Condition,... Jan 28 2016
Mead Johnson Nutrition Delivers Earnings Per Share Above Guidance for Fourth Quarter and Full Year... Jan 28 2016
Q4 2015 Mead Johnson Nutrition Co Earnings Release - Before Market Open Jan 28 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK